PI
At Protein Immunovation we are pioneering oncotherapeutic and anti-viral proteins, and the means by which they are delivered.
Colon cancer is the 2nd leading cause of cancer deaths worldwide.
More than 1.9 million people are diagnosed every year.
Yet current immunotherapies remain expensive and difficult to administer.
Our mission is to deliver a new generation of more affordable, easier-to-administer immunotherapy — so that better treatment for colon cancer patients is no longer out of reach.